Literature DB >> 6533615

Prazosin for refractory cardiac failure in children.

H Netz, K J Hagel, G Röhner, H W Rautenburg.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6533615     DOI: 10.1007/BF02424981

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


× No keyword cloud information.
  7 in total

Review 1.  Vasodilator therapy of heart failure. Has the promissory note been paid?

Authors:  E Braunwald; W S Colucci
Journal:  N Engl J Med       Date:  1984-02-16       Impact factor: 91.245

2.  Long-term therapy of heart failure with prazosin: a randomized double blind trial.

Authors:  W S Colucci; J Wynne; B L Holman; E Braunwald
Journal:  Am J Cardiol       Date:  1980-02       Impact factor: 2.778

Review 3.  The role of vasodilator therapy in heart failure.

Authors:  K Chatterjee; W W Parmley
Journal:  Prog Cardiovasc Dis       Date:  1977 Jan-Feb       Impact factor: 8.194

4.  Comparative hemodynamic effects of intravenous nitroprusside and oral prazosin in refractory heart failure.

Authors:  J Mehta; M Iacona; R L Feldman; C J Pepine; C R Conti
Journal:  Am J Cardiol       Date:  1978-05-01       Impact factor: 2.778

5.  [Chronic administration of prazosin in patients with congestive cardiomyopathy (author's transl)].

Authors:  H Kuhn; H Boch; B Lösse
Journal:  Z Kardiol       Date:  1981-07

6.  Vasodilator therapy for congestive heart failure.

Authors:  T R Dillon; G G Janos; R A Meyer; G Benzing; S Kaplan
Journal:  J Pediatr       Date:  1980-04       Impact factor: 4.406

7.  Comparison of effects of nitroprusside and prazosin on left ventricular function and the peripheral circulation in chronic refractory congestive heart failure.

Authors:  N A Awan; R R Miller; D T Mason
Journal:  Circulation       Date:  1978-01       Impact factor: 29.690

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.